Common Contracts

EX-10.1 2 ex10-1.htm Execution Version STOCK PURCHASE AGREEMENT DATED AS OF AUGUST 30, 2018 BY AND BETWEEN BIOTIME, INC., AGEX THERAPEUTICS, INC. AND JUVENESCENCE LIMITED Page (continued) Page (continued) Page Exhibits Exhibit A Convertible Promissory...

Stock Purchase Agreement • May 5th, 2020 • New York

• Contract Type
  Stock Purchase Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  New York

THIS STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of August 30, 2018, is made by and between BioTime, Inc., a California corporation (“Seller”), AgeX Therapeutics, Inc., a Delaware corporation (the “Company”) and Juvenescence Limited, a British Virgin Islands company (“Buyer”).

STOCK PURCHASE AGREEMENT DATED AS OF AUGUST 30, 2018 BY AND BETWEEN BIOTIME, INC., AGEX THERAPEUTICS, INC. AND JUVENESCENCE LIMITED

Stock Purchase Agreement • August 31st, 2018 • Biotime Inc • Biological products, (no disgnostic substances) • New York

• Contract Type
  Stock Purchase Agreement
• Filed
  August 31st, 2018
• Company
  Biotime Inc
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

THIS STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of August 30, 2018, is made by and between BioTime, Inc., a California corporation (“Seller”), AgeX Therapeutics, Inc., a Delaware corporation (the “Company”) and Juvenescence Limited, a British Virgin Islands company (“Buyer”).